Demant A/S Unsponsored ADR (OTCMKTS:WILYY) Stock Short Interest Report for October

Key Points

• Short interest rose 209.5% in October to 65 shares from 21, but short positions represent 0.0% of outstanding shares and only 0.2 days of average trading volume.
• WILYY opened at $26.60, above its 50-day moving average of $24.22 and 200-day average of $19.21, and remains near its 12-month high of $28.10.
• UBS, Sanford C. Bernstein, and Zacks Research each downgraded Demant to “Hold”; despite three Hold ratings, the stock maintains a “Moderate Buy” consensus.

Demant A/S Unsponsored ADR (OTCMKTS:WILYY - Get Free Report) was the recipient of a significant growth in short interest during the month of October. As of October 15th, there was short interest totaling 65 shares, a growth of 209.5% from the September 30th total of 21 shares. Based on an average daily volume of 353 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.0% of the company's stock are short sold.

Demant A/S Price Performance

WILYY opened at $26.60 on Thursday. The firm has a 50 day moving average price of $24.22 and a 200-day moving average price of $19.21. Demant A/S has a twelve month low of $13.45 and a twelve month high of $28.10.

Analyst Ratings Changes

A number of research analysts have recently issued reports on WILYY shares. UBS Group downgraded Demant A/S from a "strong-buy" rating to a "hold" rating in a report on Wednesday, July 22nd. Sanford C. Bernstein downgraded Demant A/S from a "strong-buy" rating to a "hold" rating in a report on Friday, July 17th. Finally, Zacks Research downgraded Demant A/S from a "strong-buy" rating to a "hold" rating in a report on Monday, October 12th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy".

About Demant A/S

Demant A/S is a Denmark-based hearing healthcare company that develops, manufactures and distributes products and services designed to help people with hearing loss and related communication needs. Its business includes hearing aids, hearing implants, audiological diagnostic equipment, and software and technology used by hearing care professionals.

The company's principal hearing aid brands include Oticon and Bernafon, while its portfolio also includes Philips Hearing Solutions products developed through its partnership with Koninklijke Philips.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.